Valneva
Hanneke Schuitemaker is a distinguished scientific leader, currently serving as the Chief Scientific Officer at Valneva. With a strong academic foundation as a Professor in Virology at the Academic Medical Centre, University of Amsterdam, Hanneke has an extensive career in the pharmaceutical industry, previously holding roles such as Vice President and Global Head of Viral Vaccine Discovery and Translational Medicine at Janssen Pharmaceuticals and Senior Vice President at Crucell Holland BV. Hanneke's educational background includes a degree from Vrije Universiteit Amsterdam, complemented by early education at Han Fortmann College.
This person is not in any offices
Valneva
2 followers
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.